RxDoctor Payments Data

Donna McDonald, APRN

Psychiatric/Mental Health · Providence, RINPI 1760858211

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,193 of the $9,085 with a category attached, or 79.2%. It is spread thinly across 24 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,153, more than ten times the $138 reported in 2022. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,085in general payments, 2019–2025

Across 138 payments — averaging $65.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • AbbVie$670
  • Otsuka America Pharmaceutical, Inc.$473
  • Vanda Pharmaceuticals Inc.$449
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$1,73319%
  • Food & beverage$7,19379%
  • Education$1602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,085 in reported general payments places this provider in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.

See all psychiatric/mental health providers in Rhode Island

Medicare billing

Part B allowed, 2024
$18,814
Medicare patients
57
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl22$1,064
Bupropion XlBupropion Hcl26$640
Buspirone Hcl23$393
Mirtazapine20$265
Sertraline Hcl20$263
Alprazolam26$223
Aripiprazole12$213
Hydroxyzine Hcl15$75
Venlafaxine Hcl ErVenlafaxine Hcl13$58
Fluoxetine Hcl12$50

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →